News

Blog

COMPETE Clinical Trial

A new phase III clinical trial called COMPETE (NCT03049189 ) compares everolimus, an oral targeted therapy, to PRRT with Lu-177 edotreotide, a radiopharmaceutical under development,

Read More »
Blog

A Look at Lung NETs

Approximately 20% of all primary lung tumors are neuroendocrine (Hung 2019), including: Typical carcinoid (TC) Atypical carcinoid (AC) Small cell carcinoma (SCC) Large cell carcinoma

Read More »
Blog

Make Your Voice Heard

Access to a NET diagnostic scan, called Gallium-68 dotatate, could change in 2020 if reimbursement falls as planned. Use your voice to express support for continued access.

Read More »
Blog

Staying Safe from the Flu

Living with cancer increases your risk for complications from influenza (“flu”). If you have cancer now, have had cancer in the past, or live with

Read More »
Blog

A Great Day for a Victory Lap

Almost 2 years after his NET diagnosis, Maros Felsen organizes and runs a 5K neuroendocrine cancer fundraiser. He’s proof for all that you can lead an active, meaningful, and successful life with neuroendocrine cancer.

Read More »
Blog

Biking for Debbie

Vicki Dailey organizes an annual two-state, 82-mile bikeride to honor her sister’s experience with neuroendocrine cancer to move us closer to a cure.

Read More »
Blog

Painting the Town Zebra-Striped

A small town in Maine finds its zebra stripes after two first responders and a town official succumbed to NETs since 2017. See how they are raising awareness and money for research.

Read More »